Coronavirus Disease 2019 (COVID‐19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Tongji Hospital · Huazhong University of Science and Technology
Abstract
He prevalence of coronavirus disease 2019 (COVID-19) has posed a great threat to people's health worldwide, bringing a great challenges to the public healthcare systems. A recent study has confirmed that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses severe acute respiratory syndrome coronavirus (SARS-CoV) receptor angiotensin-converting enzyme 2 (ACE2) for host cell entry. 1 ACE2 expression was previously found to correlate with susceptibility to SARS-CoV infection in vitro.
Citation impact
- FWCI
- 11.83
- Percentile
- 100%
- References
- 18
Authors
4- JGJunyi GuoCorresponding
Tongji Hospital, Huazhong University of Science and Technology
- ZHZheng Huang
Tongji Hospital, Huazhong University of Science and Technology
- LLLi Lin
Tongji Hospital, Huazhong University of Science and Technology
- JLJiagao Lv
Tongji Hospital, Huazhong University of Science and Technology
Topics & keywords
- Medicine
- Angiotensin Receptor Blockers
- Internal medicine
- Angiotensin-converting enzyme
- Blood pressure